The FOXE1 locus is a major genetic determinant for familial nonmedullary thyroid carcinoma

International Journal of Cancer

Volumn 134, Issue 9, 2014, Pages 2098-2107

  Bonora, Elena ^a   Rizzato, Cosmeri ^b   Diquigiovanni, Chiara ^a   Oudot Mellakh, Tiphaine ^c   Campa, Daniele ^b   Vargiolu, Manuela ^a,f   Guedj, Mickaël ^d   McKay, James D ^e   Romeo, Giovanni ^a,f   Canzian, Federico ^b   Lesueur, Fabienne ^e,f  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d Pharnext ^*  (France)

^e INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^f INSERM U900   (France)

Author keywords

genetic association study; genetic predisposition; nonmedullary thyroid carcinoma; single nucleotide polymorphisms

Indexed keywords

ARTICLE; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; FOXE1 GENE; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPING TECHNIQUE; HAPLOTYPE; HIGH RISK POPULATION; HUMAN; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; ONCOGENE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; THYROID CARCINOMA;

GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; NONMEDULLARY THYROID CARCINOMA; SINGLE NUCLEOTIDE POLYMORPHISMS;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA MUTATIONAL ANALYSIS; FORKHEAD TRANSCRIPTION FACTORS; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; PEDIGREE; POLYMORPHISM, SINGLE NUCLEOTIDE; THYROID NEOPLASMS;

EID: 84896732395     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28543     Document Type: Article

References (49)

1. Schlumberger MJ,. Papillary and follicular thyroid carcinoma. N Engl J Med 1998; 338: 297-306.
2. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-917.
3. Goldgar DE, Easton DF, Cannon-Albright LA, et al. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 1994; 86: 1600-8.
4. Hemminki K, Vaittinen P,. Effect of paternal and maternal cancer on cancer in the offspring: a population-based study. Cancer Epidemiol Biomarkers Prev 1997; 6: 993-7.
5. Fagin JA,. Familial nonmedullary thyroid carcinoma-the case for genetic susceptibility. J Clin Endocrinol Metab 1997; 82: 342-4.
6. Grossman RF, Tu SH, Duh QY, et al. Familial nonmedullary thyroid cancer. An emerging entity that warrants aggressive treatment. Arch Surg 1995; 130: 892-7; discussion 8-9.
7. Lesueur F, Stark M, Tocco T, et al. Genetic heterogeneity in familial nonmedullary thyroid carcinoma: exclusion of linkage to RET, MNG1, and TCO in 56 families. NMTC Consortium. J Clin Endocrinol Metab 1999; 84: 2157-62.
8. Malchoff CD, Malchoff DM,. Familial nonmedullary thyroid carcinoma. Cancer Control 2006; 13: 106-10.
9. Sippel RS, Caron NR, Clark OH,. An evidence-based approach to familial nonmedullary thyroid cancer: screening, clinical management, and follow-up. World J Surg 2007; 31: 924-33.
10. Bignell GR, Canzian F, Shayeghi M, et al. Familial nontoxic multinodular thyroid goiter locus maps to chromosome 14q but does not account for familial nonmedullary thyroid cancer. Am J Hum Genet 1997; 61: 1123-30.
11. Canzian F, Amati P, Harach HR, et al. A gene predisposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2. Am J Hum Genet 1998; 63: 1743-8.
12. McKay JD, Lesueur F, Jonard L, et al. Localization of a susceptibility gene for familial nonmedullary thyroid carcinoma to chromosome 2q21. Am J Hum Genet 2001; 69: 440-6.
13. Malchoff CD, Sarfarazi M, Tendler B, et al. Papillary thyroid carcinoma associated with papillary renal neoplasia: genetic linkage analysis of a distinct heritable tumor syndrome. J Clin Endocrinol Metab 2000; 85: 1758-64.
14. Cavaco BM, Batista PF, Martins C, et al. Familial non-medullary thyroid carcinoma (FNMTC): analysis of fPTC/PRN, NMTC1, MNG1 and TCO susceptibility loci and identification of somatic BRAF and RAS mutations. Endocr Relat Cancer 2008; 15: 207-15.
15. He H, Nagy R, Liyanarachchi S, et al. A susceptibility locus for papillary thyroid carcinoma on chromosome 8q24. Cancer Res 2009; 69: 625-31.
16. Rio Frio T, Bahubeshi A, Kanellopoulou C, et al. DICER1 mutations in familial multinodular goiter with and without ovarian Sertoli-Leydig cell tumors. JAMA 2011; 305: 68-77.
17. Gudmundsson J, Sulem P, Gudbjartsson DF, et al. Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nat Genet 2009; 41: 460-4.
18. Baida A, Akdi M, Gonzalez-Flores E, et al. Strong association of chromosome 1p12 loci with thyroid cancer susceptibility. Cancer Epidemiol Biomarkers Prev 2008; 17: 1499-504.
19. Suh I, Filetti S, Vriens MR, et al. Distinct loci on chromosome 1q21 and 6q22 predispose to familial nonmedullary thyroid cancer: a SNP array-based linkage analysis of 38 families. Surgery 2009; 146: 1073-80.
20. Cavaco BM, Batista PF, Sobrinho LG, et al. Mapping a new familial thyroid epithelial neoplasia susceptibility locus to chromosome 8p23.1-p22 by high-density single-nucleotide polymorphism genome-wide linkage analysis. J Clin Endocrinol Metab 2008; 93: 4426-30.
21. Jazdzewski K, Murray EL, Franssila K, et al. Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci USA 2008; 105: 7269-74.
22. Jazdzewski K, Liyanarachchi S, Swierniak M, et al. Polymorphic mature microRNAs from passenger strand of pre-miR-146a contribute to thyroid cancer. Proc Natl Acad Sci USA 2009; 106: 1502-5.
23. Cancemi L, Romei C, Bertocchi S, et al. Evidences that the polymorphism Pro-282-Ala within the tumor suppressor gene WWOX is a new risk factor for differentiated thyroid carcinoma. Int J Cancer 2011; 129: 2816-24.
24. Arnaud-Lopez L, Usala G, Ceresini G, et al. Phosphodiesterase 8B gene variants are associated with serum TSH levels and thyroid function. Am J Hum Genet 2008; 82: 1270-80.
25. Laird NM, Horvath S, Xu X,. Implementing a unified approach to family-based tests of association. Genet Epidemiol 2000; 19 (Suppl 1): S36-S42.
26. Wigginton JE, Abecasis GR,. PEDSTATS: descriptive statistics, graphics and quality assessment for gene mapping data. Bioinformatics 2005; 21: 3445-7.
27. Landa I, Ruiz-Llorente S, Montero-Conde C, et al. The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1/USF2 transcription factors. PLoS Genet 2009; 5: e1000637.
28. Spielman RS, McGinnis RE, Ewens WJ,. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993; 52: 506-16.
29. Lange C, Laird NM,. Power calculations for a general class of family-based association tests: dichotomous traits. Am J Hum Genet 2002; 71: 575-84.
30. Thornton T, McPeek MS,. Case-control association testing with related individuals: a more powerful quasi-likelihood score test. Am J Hum Genet 2007; 81: 321-37.
31. Xu H, Shete S,. Mixed-effects logistic approach for association following linkage scan for complex disorders. Ann Hum Genet 2007; 71: 230-7.
32. MacDermot KD, Bonora E, Sykes N, et al. Identification of FOXP2 truncation as a novel cause of developmental speech and language deficits. Am J Hum Genet 2005; 76: 1074-80.
33. Macchia PE, Mattei MG, Lapi P, et al. Cloning, chromosomal localization and identification of polymorphisms in the human thyroid transcription factor 2 gene (TITF2). Biochimie 1999; 81: 433-40.
34. Castanet M, Polak M,. Spectrum of human Foxe1/TTF2 mutations. Horm Res Paediatr 2010; 73: 423-9.
35. Carre A, Castanet M, Sura-Trueba S, et al. Polymorphic length of FOXE1 alanine stretch: evidence for genetic susceptibility to thyroid dysgenesis. Hum Genet 2007; 122: 467-76.
36. Takahashi M, Saenko VA, Rogounovitch TI, et al. The FOXE1 locus is a major genetic determinant for radiation-related thyroid carcinoma in Chernobyl. Hum Mol Genet 2010; 19: 2516-23.
37. Matsuse M, Takahashi M, Mitsutake N, et al. The FOXE1 and NKX2-1 loci are associated with susceptibility to papillary thyroid carcinoma in the Japanese population. J Med Genet 2011; 48: 645-8.
38. Tomaz RA, Sousa I, Silva JG, et al. FOXE1 polymorphisms are associated with familial and sporadic nonmedullary thyroid cancer susceptibility. Clin Endocrinol 2012; 77: 926-33.
39. Bullock M, Duncan EL, O'Neill C, et al. Association of FOXE1 polyalanine repeat region with papillary thyroid cancer. J Clin Endocrinol Metab 2012; 97: E1814-E1819.
40. Ngan ES, Lang BH, Liu T, et al. A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma. J Natl Cancer Inst 2009; 101: 162-75.
41. Risch N, Teng J,. The relative power of family-based and case-control designs for linkage disequilibrium studies of complex human diseases. DNA pooling. Genome Res 1998; 8: 1273-88.
42. Risch N, Merikangas K,. The future of genetic studies of complex human diseases. Science 1996; 273: 1516-17.
43. Parlato R, Rosica A, Rodriguez-Mallon A, et al. An integrated regulatory network controlling survival and migration in thyroid organogenesis. Dev Biol 2004; 276: 464-75.
44. Zannini M, Avantaggiato V, Biffali E, et al. TTF-2, a new forkhead protein, shows a temporal expression in the developing thyroid which is consistent with a role in controlling the onset of differentiation. EMBO J 1997; 16: 3185-97.
45. Takahashi M, Saenko VA, Rogounovitch TI, et al. The FOXE1 locus is a major genetic determinant for radiation-related thyroid carcinoma in Chernobyl. Hum Mol Genet 2010; 19: 2516-23.
46. Kallel R, Belguith-Maalej S, Akdi A, et al. Genetic investigation of FOXE1 polyalanine tract in thyroid diseases: new insight on the role of FOXE1 in thyroid carcinoma. Cancer Biomark 2010; 8: 43-51.
47. Gasbarri A, Tavares MC, Rodrigues RC, et al. Estrogen, cognitive functions and emotion: an overview on humans, non-human primates and rodents in reproductive years. Rev Neurosci 2012; 23: 587-606.
48. Hemminki K, Forsti A, Lorenzo Bermejo J,. New cancer susceptibility loci: population and familial risks. Int J Cancer 2008; 123: 1726-9.
49. Fan Y, Ding Z, Yang Z, et al. Expression and clinical significance of FOXE1 in papillary thyroid carcinoma. Mol Med Rep 2013; 8: 123-7.